<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">20980524</PMID>
        <DateCompleted>
            <Year>2011</Year>
            <Month>01</Month>
            <Day>20</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-5514</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>85</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2011</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of virology</Title>
                <ISOAbbreviation>J. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>208-16</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01810-10</ELocationID>
            <Abstract>
                <AbstractText>Type 1 interferons (IFNs) induce the expression of the tripartite interaction motif (TRIM) family of E3 ligases, but the contribution of these antiviral factors to HIV pathogenesis is not completely understood. We hypothesized that the increased expression of select type 1 IFN and TRIM isoforms is associated with a significantly lower likelihood of HIV-1 acquisition and viral control during primary HIV-1 infection. We measured IFN-α, IFN-β, myxovirus resistance protein A (MxA), human TRIM5α (huTRIM5α), and TRIM22 mRNA levels in peripheral blood mononuclear cells (PBMCs) of high-risk, HIV-1-uninfected participants and HIV-1-positive study participants. Samples were available for 32 uninfected subjects and 28 infected persons, all within 1 year of infection. HIV-1-positive participants had higher levels of IFN-β (P = 0.0005), MxA (P = 0.007), and TRIM22 (P = 0.01) and lower levels of huTRIM5α (P &lt; 0.001) than did HIV-1-negative participants. TRIM22 but not huTRIM5α correlated positively with type 1 IFN (IFN-α, IFN-β, and MxA) (all P &lt; 0.0001). In a multivariate model, increased MxA expression showed a significant positive association with viral load (P = 0.0418). Furthermore, TRIM22 but not huTRIM5α, IFN-α, IFN-β, or MxA showed a negative correlation with plasma viral load (P = 0.0307) and a positive correlation with CD4(+) T-cell counts (P = 0.0281). In vitro studies revealed that HIV infection induced TRIM22 expression in PBMCs obtained from HIV-negative donors. Stable TRIM22 knockdown resulted in increased HIV-1 particle release and replication in Jurkat reporter cells. Collectively, these data suggest concordance between type 1 IFN and TRIM22 but not huTRIM5α expression in PBMCs and that TRIM22 likely acts as an antiviral effector in vivo.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Singh</LastName>
                    <ForeName>Ravesh</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Doris Duke Medical Research Institute, University of KwaZulu-Natal, Private Bag X7, Congella, Durban 4001, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gaiha</LastName>
                    <ForeName>Gaurav</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Werner</LastName>
                    <ForeName>Lise</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McKim</LastName>
                    <ForeName>Kevin</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mlisana</LastName>
                    <ForeName>Koleka</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Luban</LastName>
                    <ForeName>Jeremy</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Walker</LastName>
                    <ForeName>Bruce D</ForeName>
                    <Initials>BD</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karim</LastName>
                    <ForeName>Salim S Abdool</ForeName>
                    <Initials>SS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brass</LastName>
                    <ForeName>Abraham L</ForeName>
                    <Initials>AL</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ndung'u</LastName>
                    <ForeName>Thumbi</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>CAPRISA Acute Infection Study Team</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 AI059159</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U19 AI051794</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01AI059159</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U19 AI 51794</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2010</Year>
                <Month>10</Month>
                <Day>27</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Virol</MedlineTA>
            <NlmUniqueID>0113724</NlmUniqueID>
            <ISSNLinking>0022-538X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016898">Interferon-alpha</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C579071">MX1 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015778">Minor Histocompatibility Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D064547">Myxovirus Resistance Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012097">Repressor Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C094314">TRIM22 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000070584">Tripartite Motif Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>77238-31-4</RegistryNumber>
                <NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.6.1.-</RegistryNumber>
                <NameOfSubstance UI="D019204">GTP-Binding Proteins</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019204" MajorTopicYN="N">GTP-Binding Proteins</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016898" MajorTopicYN="N">Interferon-alpha</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019169" MajorTopicYN="N">Jurkat Cells</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015778" MajorTopicYN="N">Minor Histocompatibility Antigens</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D064547" MajorTopicYN="N">Myxovirus Resistance Proteins</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012097" MajorTopicYN="N">Repressor Proteins</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000070584" MajorTopicYN="N">Tripartite Motif Proteins</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2010</Year>
                <Month>10</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2010</Year>
                <Month>10</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2011</Year>
                <Month>1</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">20980524</ArticleId>
            <ArticleId IdType="pii">JVI.01810-10</ArticleId>
            <ArticleId IdType="doi">10.1128/JVI.01810-10</ArticleId>
            <ArticleId IdType="pmc">PMC3014203</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Microbiol. 2005 Oct;3(10):799-808</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16175175</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Gene Ther. 2005 Oct;16(10):1125-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16218773</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2005 Nov 1;175(9):6117-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16237108</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioessays. 2005 Nov;27(11):1147-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16237670</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2005 Dec 30;338(4):1950-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16289103</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2006 Mar;80(5):2463-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16474153</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2006 Mar 24;124(6):1283-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16564017</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2006 Sep 15;353(1):234-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16808955</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Retrovirology. 2006;3:54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16925802</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2006 Dec 5-20;356(1-2):79-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16926043</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2007 Apr 19;446(7138):916-920</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17392790</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2007 Sep;81(18):10201-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17609277</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2007 Oct 1;21(15):2015-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17885291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Interferon Cytokine Res. 2007 Oct;27(10):857-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17970695</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Immunol. 2008 Mar;38(3):619-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18286572</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2008 Feb;4(2):e1000007</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18389079</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2008;3(4):e1954</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18414658</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2008 Feb 8;4(2):e16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18248090</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2008 Feb 8;4(2):e18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18248091</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2008 Jul;8(7):559-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18575461</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):522-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18645522</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2008 Oct;14(10):1077-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18806803</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2008 Nov;8(11):849-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18836477</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmunol. 2009 Jan 3;206(1-2):14-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19027180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2009;4(3):e4894</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19290053</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biofactors. 2009 Jan-Feb;35(1):14-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19319841</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2009 Jun 1;199(11):1657-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19388851</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Interferon Cytokine Res. 1999 Oct;19(10):1069-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10547147</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 2001 May 1;20(9):2140-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11331580</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2002 Sep 6;297(5587):1703-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12215647</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2004 Feb 26;427(6977):848-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14985764</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10774-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15249685</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10786-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15249690</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2004 Jul 29;430(6999):569-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15243629</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11827-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15280539</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Immunol. 1990 Sep;20(9):2015-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2120071</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS Res Hum Retroviruses. 1996 May 1;12(7):585-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8743084</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genomics. 1996 May 15;34(1):151-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8661041</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2004 Nov;4(11):868-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15516966</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Genet. 2004;38:61-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15568972</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS Res Hum Retroviruses. 2004 Nov;20(11):1210-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15588343</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2832-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15689398</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2005 Jul 15;192(2):303-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15962225</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2009 May 28;113(22):5497-505</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19299650</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS Res Hum Retroviruses. 2009 Jun;25(6):577-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19500019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2009 Dec 24;139(7):1243-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20064371</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>